SCHEMBL14735892

SCHEMBL14735892

O=C(O)C(OC(C(=O)O)c1ccccc1[N+](=O)[O-])c1ccccc1[N+](=O)[O-]

nearest known ligand 0.61

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.61
TSHR P16473 2/20 0.58
ALDH1A1 P00352 6/20 0.55
TDP1 Q9NUW8 3/20 0.46
MAPT P10636 1/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
GPR35 Q9HC97 1/20 0.41
HSD17B10 Q99714 1/20 0.40
CTSD P07339 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7133361 0.87 ALDH1A1 (0.60) CYP1A2TSHRALDH1A1TDP1MAPT
SCHEMBL8808242 0.84 CYP1A2 (0.55) CYP1A2TSHRALDH1A1TDP1MAPT
SCHEMBL7877336 0.84 CYP1A2 (0.55) CYP1A2TSHRALDH1A1TDP1MAPT
SCHEMBL8808237 0.84 CYP1A2 (0.55) CYP1A2TSHRALDH1A1TDP1MAPT
SCHEMBL27815461 0.83 CYP1A2 (0.55) CYP1A2TSHRALDH1A1MAPTMEN1
SCHEMBL14733944 0.82 ALDH1A1 (0.55) CYP1A2TSHRALDH1A1TDP1MAPT
SCHEMBL16335086 0.80 CYP1A2 (0.67) CYP1A2TSHRALDH1A1TDP1MAPT
SCHEMBL2598761 0.80 CYP1A2 (0.67) CYP1A2TSHRALDH1A1TDP1MAPT
SCHEMBL16335088 0.80 CYP1A2 (0.67) CYP1A2TSHRALDH1A1TDP1MAPT
SCHEMBL6605025 0.80 CYP1A2 (0.67) CYP1A2TSHRALDH1A1TDP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013029723-A1 NOVEL PHOTOACTIVATABLE PACLITAXEL DERIVATIVES AND USES THEREOF, IN PARTICULAR IN CELLBIOLOGY AND CANCER TREATMENT MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V. (DE) 2013-03-07 WO claimed
EP-2565188-A1 Novel photoactivatable paclitaxel derivatives and uses thereof, in particular in cellbiology and cancer treatment Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2013-03-06 EP claimed
WO-2013029723-A1 NOVEL PHOTOACTIVATABLE PACLITAXEL DERIVATIVES AND USES THEREOF, IN PARTICULAR IN CELLBIOLOGY AND CANCER TREATMENT MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V. (DE) 2013-03-07 WO disclosed
EP-2565188-A1 Novel photoactivatable paclitaxel derivatives and uses thereof, in particular in cellbiology and cancer treatment Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2013-03-06 EP disclosed
EP-2565188-A1 Novel photoactivatable paclitaxel derivatives and uses thereof, in particular in cellbiology and cancer treatment Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2013-03-06 EP disclosed